Prolonged-release Potassium Chloride Generics

Form: Tablet

Strength: 8 mEq (600 mg), 10 mEq (750 mg), 15mEq (1,125 mg), 20mEq (1,500 mg)

Reference Brands: Klor-Con®, K-Dur®, K-Tab®, Micro-K® (US), KCl Retard®, Kaleorid®, Kalium-Retard®, Slow-K® (EU)

Category: Nephrology

Prolonged-release Potassium Chloride is a vital electrolyte supplement used to treat and prevent hypokalemia in patients with chronic kidney disease (CKD), heart conditions, or those on diuretic therapy. Designed for steady potassium release, it helps maintain optimal serum potassium levels, reducing the risk of cardiac arrhythmias and muscle dysfunction. Widely prescribed in both the US and EU, it plays a crucial role in nephrology and cardiology. Ideal for B2B pharmaceutical supply, it is available in various strengths to meet diverse patient needs. Prolonged-release Potassium Chloride supports safe, effective potassium repletion in renal and electrolyte management protocols.